US 8,979,839 B2Grant

Assembly of staggered ablation elements

Issue Date:2015-03-17

•8 Claims

•10 Drawing Sheets

Abstract

An ablation catheter comprises a catheter body extending longitudinally between a proximal end and a distal end along a longitudinal axis; and an ablation element assembly comprising ablation elements connected to the catheter body, each ablation element to be energized to produce an ablation zone. The ablation elements are distributed in a staggered configuration such that the ablation zones of the ablation elements span one or more open arc segments around the longitudinal axis, but the ablation zones of all ablation elements projected longitudinally onto any lateral plane which is perpendicular to the longitudinal axis span a substantially closed loop around the longitudinal axis. Since the ablation zones do not form a closed loop, the risk of renal artery/vein stenosis is reduced or eliminated. Since the ablation zones of all ablation elements projected longitudinally onto any lateral plane span a substantially closed loop, substantially complete renal denervation is achieved.

Metadata

Assignee

St. Jude Medical, Inc.

Inventors

Alan De La Rama
Cary Hata

Application Information

Application Number:US 12/945,982

Filing Date:2010-11-15

Priority Date:2009-11-13

Art Unit:3739

Classifications

IPC:

A61B18/14A61B17/00A61B18/00A61B18/12

Field of Search:

A61B 18/04A61B 18/12A61B 18/14A61B 18/148A61B 18/1402A61B 18/1442A61B 18/1445A61B 18/1477A61B 18/1492A61B 18/18A61B 18/082A61B 2018/00214A61B 2018/00267A61B 2018/14A61B 2018/1405A61B 2018/1407A61B 2018/1467A61B 2018/1475A61B 2018/141A61B 5/6858

Patent Drawings (10 sheets)

Description

Related Applications

[0001] This application is based on and claims the benefit of U.S. Provisional Patent Application No. 61/260,978, filed on Nov. 13, 2009.

Background of the Invention

[0002] The present invention relates generally to ablation devices and, more specifically, to an assembly of ablation elements arranged in a staggered configuration.

[0003] Hypertension is a major global public health concern. An estimated 30-40% of the adult population in the developed world suffers from this condition. Furthermore, its prevalence is expected to increase, especially in developing countries. Diagnosis and treatment of hypertension remain suboptimal, even in developed countries. Despite the availability of numerous safe and effective pharmacological therapies, including fixed-drug combinations, the percentage of patients achieving adequate blood-pressure control to guideline target values remains low. Much failure of the pharmacological strategy to attain adequate blood-pressure control is attributed to both physician inertia and patient non-compliance and non-adherence to a lifelong pharmacological therapy for a mainly asymptomatic disease. Thus, the development of new approaches for the management of hypertension is a priority. These considerations are especially relevant to patients with so-called resistant hypertension (i.e., those unable to achieve target blood-pressure values despite multiple drug therapies at the highest tolerated dose). Such patients are at high risk of major cardiovascular events.

[0004] Renal sympathetic efferent and afferent nerves, which lie within and immediately adjacent to the wall of the renal artery, are crucial for initiation and maintenance of systemic hypertension. Indeed, sympathetic nerve modulation as a therapeutic strategy in hypertension had been considered long before the advent of modern pharmacological therapies. Radical surgical methods for thoracic, abdominal, or pelvic sympathetic denervation had been successful in lowering blood pressure in patients with so-called malignant hypertension. However, these methods were associated with high perioperative morbidity and mortality and long-term complications, including bowel, bladder, and erectile dysfunction, in addition to severe postural hypotension. Renal denervation is the application of a chemical agent, or a surgical procedure, or the application of energy to partially or completely damage renal nerves to partially or completely block the renal nerve activities. Renal denervation reduces or completely block renal sympathetic nerve activity, increases renal blood flow (RBF), and decreases renal plasma norepinephrine (NE) content.

[0005] The objective of renal denervation is to neutralize the effect of renal sympathetic system which is involved in arterial hypertension. Device-based renal denervation may achieve such objective, but may produce possible complications of renal artery/vein stenosis. Thus, there is a need for a device that can perform renal denervation with reduced risk of renal artery/vein stenosis.

Brief Summary of the Invention

[0006] Embodiments of the present invention are directed to an assembly of staggered ablation elements which are energized to produce ablation zones that span one or more open arc segments around the longitudinal axis, but the ablation zones of all the ablation elements projected longitudinally onto any lateral plane which is perpendicular to the longitudinal axis span a substantially closed loop around the longitudinal axis. The renal nerves are oriented generally longitudinally. Because the ablation zones do not form a closed loop, the risk of renal artery/vein stenosis is reduced or eliminated. On the other hand, because the ablation zones of all the ablation elements projected longitudinally onto any lateral plane span a substantially closed loop, a substantially complete renal denervation is achieved.

[0007] In accordance with an aspect of the present invention, an ablation catheter comprises an elongated catheter body extending longitudinally between a proximal end and a distal end along a longitudinal axis; and an ablation element assembly comprising a plurality of ablation elements connected to the catheter body, each ablation element to be energized to produce an ablation zone. The ablation elements are distributed in a staggered configuration such that the ablation zones of the ablation elements span one or more open arc segments around the longitudinal axis, and the ablation zones of all the ablation elements projected longitudinally onto any lateral plane which is perpendicular to the longitudinal axis span a substantially closed loop around the longitudinal axis.

[0008] In some embodiments, the ablation elements are discretely spaced from each other at least one of longitudinally or laterally, and at least two of the ablation elements are spaced from one another longitudinally. The ablation elements span one or more open arc segments around the longitudinal axis, but all the ablation elements projected longitudinally onto any lateral plane which is perpendicular to the longitudinal axis span a substantially closed loop around the longitudinal axis. The plurality of ablation elements are RF electrodes. The ablation elements are independently controlled to be energized in one of simultaneous manner, sequential manner, and arbitrary manner to produce the ablation zones.

[0009] In accordance with another aspect of the invention, an ablation catheter comprises an elongated catheter body extending longitudinally between a proximal end and a distal end along a longitudinal axis; and an electrode assembly comprising a plurality of ablation electrodes connected to the catheter body by resilient biasing members that bias the ablation electrodes outwardly away from the catheter body, each ablation electrode to be energized to produce an ablation zone. The electrode assembly is movable between a collapsed arrangement and an expanded arrangement, the resilient biasing members biasing the ablation electrodes outwardly away from the catheter body toward the expanded arrangement. The ablation electrodes are distributed in a staggered configuration such that the ablation zones of the ablation electrodes span one or more open arc segments around the longitudinal axis, and the ablation zones of all the ablation electrodes projected longitudinally onto any lateral plane which is perpendicular to the longitudinal axis span a substantially closed loop around the longitudinal axis.

[0010] In some embodiments, a plurality of temperature sensors thermally are coupled with the plurality of ablation electrodes to measure temperatures of the ablation electrodes. The catheter body includes a plurality of irrigation fluid channels near the plurality of ablation electrodes to direct irrigation fluid toward the ablation electrodes. Each one of the plurality of ablation electrodes has a corresponding resilient biasing member biasing the one ablation electrode outwardly away from the catheter body. At least some of the resilient biasing members are connected to the distal end of the catheter body. At least some of the resilient biasing members are connected to a circumferential surface of the catheter body proximal to the distal end. At least some of the ablation electrodes have a lateral dimension which is greater than a longitudinal dimension thereof. The ablation electrodes in the expanded arrangement contact surfaces to be ablated; and the ablation electrodes in the expanded arrangement span one or more open arc segments around the longitudinal axis, but all the ablation electrodes in the expanded arrangement projected longitudinally onto any lateral plane which is perpendicular to the longitudinal axis span a substantially closed loop around the longitudinal axis. The ablation electrodes are independently controlled to be energized in one of simultaneous manner, sequential manner, and arbitrary manner to produce the ablation zones

[0011] In accordance with another aspect of the invention, an ablation catheter comprises an elongated catheter body extending longitudinally between a proximal end and a distal end along a longitudinal axis; and an electrode assembly connected to the catheter body, the electrode assembly comprising a plurality of spines. Each of the spines has a proximal end connected to the catheter body and a distal end. The distal ends of the spines are connected to a spine distal junction. Each spine includes an intermediate segment, a proximal stiffness change between the proximal end and the intermediate segment of the spine, and a distal stiffness change between the distal end and the intermediate segment of the spine. The spines include a plurality of ablation electrodes on the intermediate segments, each ablation electrode to be energized to produce an ablation zone. The electrode assembly is movable between a collapsed arrangement and an expanded arrangement with the intermediate segments of the spines in the expanded arrangement moving outwardly relative to the proximal ends and distal ends of the spines with respect to the collapsed arrangement. The ablation electrodes are distributed on the intermediate segments in a staggered configuration such that the ablation zones of the ablation electrodes span one or more open arc segments around the longitudinal axis, and the ablation zones of all the ablation electrodes projected longitudinally onto any lateral plane which is perpendicular to the longitudinal axis span a substantially closed loop around the longitudinal axis.

[0012] In some embodiments, each spine includes a proximal leg coupled between the intermediate segment and the proximal end of the spine, and a distal leg coupled between the intermediate segment and the distal end of the spine. The proximal leg has a lower stiffness than the intermediate segment and the distal leg has a lower stiffness than the intermediate segment. Each spine includes a proximal hinge coupled between the proximal leg and the intermediate segment and a distal hinge coupled between the distal leg and the intermediate segment. The proximal leg is smaller in cross-section than the intermediate segment and the distal leg is smaller in cross-section than the intermediate segment. A plurality of temperature sensors thermally coupled with the plurality of ablation electrodes to measure temperatures of the ablation electrodes. The spines include a plurality of irrigation fluid channels near the plurality of ablation electrodes to direct irrigation fluid toward the ablation electrodes. At least some of the ablation electrodes have a lateral dimension which is greater than a longitudinal dimension thereof. The ablation electrodes in the expanded arrangement contact surfaces to be ablated; and the ablation electrodes in the expanded arrangement span one or more open arc segments around the longitudinal axis, but all the ablation electrodes in the expanded arrangement projected longitudinally onto any lateral plane which is perpendicular to the longitudinal axis span a substantially closed loop around the longitudinal axis. At least one of the spines includes a shape memory material that biases the spine toward the expanded arrangement.

[0013] These and other features and advantages of the present invention will become apparent to those of ordinary skill in the art in view of the following detailed description of the specific embodiments.

Brief Description of the Drawings

[0014] FIG. 1 illustrates an assembly of staggered ablation elements for a catheter according to an embodiment of the present invention.

[0015] FIG. 2 is a cross-sectional view of a spine illustrating an example of a temperature sensor and an irrigation fluid channel.

[0016] FIG. 3 illustrates an assembly of staggered ablation elements for a catheter according to another embodiment of the present invention.

[0017] FIG. 4 illustrates an assembly of staggered ablation elements for a catheter according to another embodiment of the present invention.

[0018] FIG. 5 illustrates an assembly of staggered ablation elements for a catheter according to another embodiment of the present invention.

[0019] FIG. 6 illustrates an assembly of staggered ablation elements for a catheter according to another embodiment of the present invention.

[0020] FIG. 7 illustrates an assembly of staggered ablation elements for a catheter according to another embodiment of the present invention.

[0021] FIG. 8 illustrates an assembly of staggered ablation elements for a catheter according to another embodiment of the present invention.

[0022] FIG. 9 illustrates the ablation zones of the ablation elements that span open arc segments around the longitudinal axis of the catheter.

[0023] FIG. 10 illustrates the ablation zones of all the ablation elements that, when projected longitudinally onto any lateral plane which is perpendicular to the longitudinal axis, span a substantially closed loop around the longitudinal axis of the catheter.

[0024] FIG. 11 illustrates an over-the-wire configuration for introducing the assembly of staggered ablation elements on a catheter to the surgical site by passing the guide wire through an internal lumen of the catheter.

[0025] FIG. 12 illustrates an over-the-wire configuration for introducing the assembly of staggered ablation elements on a catheter to the surgical site by passing the guide wire through a hole provided at the distal end of the assembly of staggered ablation elements.

Detailed Description of the Invention

[0026] In the following detailed description of the invention, reference is made to the accompanying drawings which form a part of the disclosure, and in which are shown by way of illustration, and not of limitation, exemplary embodiments by which the invention may be practiced. In the drawings, like numerals describe substantially similar components throughout the several views. Further, it should be noted that while the detailed description provides various exemplary embodiments, as described below and as illustrated in the drawings, the present invention is not limited to the embodiments described and illustrated herein, but can extend to other embodiments, as would be known or as would become known to those skilled in the art. Reference in the specification to “one embodiment,” “this embodiment,” or “these embodiments” means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment of the invention, and the appearances of these phrases in various places in the specification are not necessarily all referring to the same embodiment. Additionally, in the following detailed description, numerous specific details are set forth in order to provide a thorough understanding of the present invention. However, it will be apparent to one of ordinary skill in the art that these specific details may not all be needed to practice the present invention. In other circumstances, well-known structures, materials, circuits, processes and interfaces have not been described in detail, and/or may be illustrated in block diagram form, so as to not unnecessarily obscure the present invention.

[0027] In the following description, relative orientation and placement terminology, such as the terms horizontal, vertical, left, right, top and bottom, is used. It will be appreciated that these terms refer to relative directions and placement in a two dimensional layout with respect to a given orientation of the layout. For a different orientation of the layout, different relative orientation and placement terms may be used to describe the same objects or operations.

[0028] Exemplary embodiments of the invention, as will be described in greater detail below, provide assemblies of staggered ablation elements that are particularly suitable for renal denervation with a reduced risk of stenosis.

[0029] FIG. 1 illustrates an assembly of staggered ablation elements for a catheter according to an embodiment of the present invention. In the perspective view of FIG. 1a, an ablation catheter 10 includes an elongated catheter body 12 extending longitudinally between a proximal end (not shown) and a distal end 14 along a longitudinal axis 16. An ablation element assembly 20 includes a plurality of ablation elements 22 connected to the catheter body 12. The ablation elements 22 are discretely spaced from each other longitudinally and/or laterally, and at least two of the ablation elements 22 are spaced from one another longitudinally.

[0030] In this embodiment, the ablation elements 22 are electrodes such as RF electrodes. The ablation electrode assembly 20 is connected to the distal end 14 of the catheter body 12. As seen in FIGS. 1a-1d, the electrode assembly 20 includes a plurality of spines 24, which may be oriented generally longitudinally. Each spine 24 has a proximal end 26 connected to the catheter body 12 and a distal end 28. The distal ends 28 of the spines 24 are connected to a spine distal junction 30. Each spine 24 includes an intermediate segment 32, a proximal stiffness change between the proximal end 26 and the intermediate segment 32 of the spine 24, and a distal stiffness change between the distal end 28 and the intermediate segment 32 of the spine 24. The spines 24 include a plurality of ablation electrodes 22 on the intermediate segments 32.

[0031] As shown in FIG. 1b, the electrode assembly 20 is movable between a collapsed arrangement 20a and an expanded arrangement 20b with the intermediate segments 32 of the spines 24 in the expanded arrangement 20b moving outwardly relative to the proximal ends 26 and distal ends 28 of the spines 24 with respect to the collapsed arrangement 20a.

[0032] Each spine 24 includes a proximal leg 34 coupled between the intermediate segment 32 and the proximal end 26 of the spine 24, and a distal leg 36 coupled between the intermediate segment 32 and the distal end 28 of the spine 24. Each spine 24 includes a proximal hinge 44 coupled between the proximal leg 34 and the intermediate segment 32 and a distal hinge 46 coupled between the distal leg 36 and the intermediate segment 32. The hinges 44, 46 represent the stiffness changes in this embodiment to facilitate movement of the intermediate segments 32 of the spines 24 between the collapsed arrangement 20a and the expanded arrangement 20b. In addition, each spine 24 may further include a proximal end hinge 40 coupled between the proximal leg 34 and the proximal end 26 and a distal end hinge 42 coupled between the distal leg 36 and the distal end 28 to further facilitate movement of the intermediate segments 32 of the spines 24 between the collapsed arrangement 20a and the expanded arrangement 20b.

[0033] In use, the catheter 10 with the electrode assembly 20 is inserted into a blood vessel or the like in the collapsed arrangement 20a (inside a guiding sheath or the like) and deployed into the expanded arrangement 20b. To allow blood flow in the blood vessel across the electrode assembly 20 and reduce or avoid obstruction, the spine 24 in FIG. 1c has narrow intermediate segment 32, proximal leg 34, and distal leg 36. In FIG. 1d, the intermediate segment 32 is wider while the proximal leg 34 and distal leg 36 are tapered so as to be smaller in cross-section than the intermediate segment 32, thereby reducing obstruction. Furthermore, the electrode assembly 20 preferably has no sharp corners or edges but has rounded corners and edges to facilitate easier and smoother movement within the blood vessel.

[0034] The ablation electrodes 22 in the expanded arrangement 20b contact surfaces to be ablated to ablate tissue and/or denervate nerves. To ensure surface contact for the ablation electrodes 22, the intermediate segments 32 preferably have sufficient stiffness to avoid or minimize bending in the expanded arrangement 20b. The electrode assembly 20 moves from the collapsed arrangement 20a to the expanded arrangement 20b by any suitable mechanism. In one example, any or all of the proximal leg 34, the distal leg 36, the proximal end hinge 40, and the distal end hinge 42 of the spine 24 may be resiliently biased (e.g., with a spring or a memory material) to move the electrode assembly 20 toward the expanded arrangement 20b. In another example, the longitudinal rod 60 in the center of the electrode assembly 20 is connected to the spine distal junction 30, and can be used to pull the spine distal junction 30 toward the distal end 14 of the catheter body 12 to move the electrode assembly 20 toward the expanded arrangement 20b.

[0035] A plurality of temperature sensors 50 are thermally coupled with the plurality of ablation electrodes 22 to measure temperatures of the ablation electrodes. FIG. 2 is a cross-sectional view of the spine 24 illustrating an example of a temperature sensor 50 disposed adjacent the electrode 22 supported on the spine 24. In addition, the spines 24 may include a plurality of irrigation fluid channels 54 near the plurality of ablation electrodes 22 to direct irrigation fluid toward the ablation electrodes 22, as seen in FIG. 2.

[0036] FIG. 3 illustrates an assembly of staggered ablation elements for a catheter according to another embodiment of the present invention. FIG. 3a shows the electrode assembly 60 in a collapsed arrangement and FIG. 3b shows the electrode assembly 60 in an expanded arrangement. The electrode assembly 60 may be connected to the distal end of a catheter body or may be disposed proximally from the distal end of the catheter body.

[0037] The electrode assembly 60 of FIG. 3 differs from the electrode assembly 20 of FIG. 1 in several respects. First, the ablation electrodes 62 each have a lateral dimension which is greater than a longitudinal dimension thereof. The lateral dimension of the electrode 62 is greater than the lateral dimension of the spine 64 that supports the electrode 62. Each spine 64 has a proximal leg 66, a distal leg 68, and an intermediate segment 70. Each electrode 62 has the shape of a circumferential arch that produces an ablation zone that is oriented laterally with respect to the longitudinal axis. Such an ablation zone is more efficient and effective for denervating renal nerves that are oriented generally longitudinally.

[0038] Unlike the electrode assembly 20 of FIG. 1, the electrode assembly 60 of FIG. 3 does not include hinges on the spines. Instead, the spines 64 are configured to facilitate movement of the electrode assembly 60 from the collapsed arrangement to the expanded arrangement. For example, the proximal leg 66 has a lower stiffness than the intermediate segment 70 and the distal leg 68 has a lower stiffness than the intermediate segment 70. As a result, the proximal leg 66 and the distal leg 68 will bend or deform under a force that moves the electrode assembly 60 to the expanded arrangement. That force may be produced by at least one of the spines 64 made of a shape memory material (e.g., Nitinol). A longitudinal rod 65 in the center of the electrode assembly 60 may be connected to the spine distal junction 67, and can be used to pull the spine distal junction 67 in the proximal direction to move the electrode assembly 60 toward the expanded arrangement.

[0039] FIG. 4 illustrates an assembly of staggered ablation elements for a catheter according to another embodiment of the present invention. FIG. 4a shows the electrode assembly 80 in a collapsed arrangement and FIG. 4b shows the electrode assembly 80 in an expanded arrangement. The electrode assembly 80 of FIG. 4 differs from the electrode assembly 60 of FIG. 3 in one respect. Tapered/rounded corners 81 replace sharp corners to facilitate easier and smoother movement of the electrode assembly within the blood vessel. A longitudinal rod 85 in the center of the electrode assembly 80 may be connected to the spine distal junction 87, and can be used to pull the spine distal junction 87 in the proximal direction to move the electrode assembly 80 toward the expanded arrangement.

[0040] The electrode assembly 60 of FIG. 5 is similar to the electrode assembly 60 of FIG. 3. They differ only in the arrangement of the ablation electrodes 62. In FIG. 3, the ablation electrodes 62 are staggered in a spiral manner in the longitudinal direction. In FIG. 5, the ablation electrodes 62 are arranged in nearly opposite pairs. These examples illustrate a few of the many different ways to arrange the staggered ablation electrodes 62 to form the electrode assemblies 60.

[0041] The electrode assembly 80 of FIG. 6 is similar to the electrode assembly 80 of FIG. 4. They differ only in the arrangement of the ablation electrodes 82. In FIG. 4, the ablation electrodes 82 are staggered in a spiral manner in the longitudinal direction. In FIG. 6, the ablation electrodes 82 are arranged in nearly opposite pairs. These examples illustrate a few of the many different ways to arrange the staggered ablation electrodes 82 to form the electrode assemblies 80.

[0042] FIG. 7 illustrates an assembly of staggered ablation elements for a catheter according to another embodiment of the present invention. A catheter body 90 with a distal end 92 is shown. FIG. 7a shows the electrode assembly 100 in a collapsed arrangement and FIG. 7b shows the electrode assembly 100 in an expanded arrangement. A plurality of ablation electrodes 102 are connected to the circumferential surface of the catheter body 90 proximally with respect to the distal end 92. The ablation electrodes 102 rest against the circumferential surface of the catheter body 90 in the collapsed arrangement of FIG. 7a. A plurality of resilient biasing members 104 bias the ablation electrodes 102 toward the expanded arrangement of FIG. 7b. In the embodiment shown, each ablation electrode 102 has a corresponding resilient biasing member 104 biasing the one ablation electrode 102 outwardly away from the catheter body 90. The ablation electrodes 102 are circumferential arches each having a lateral dimension greater than a longitudinal dimension thereof.

[0043] FIG. 8 illustrates an assembly of staggered ablation elements for a catheter according to another embodiment of the present invention. A catheter body 110 with a distal end 112 is shown. The electrode assembly 120 includes a plurality of ablation electrodes 122 that are connected to the distal end 92 of the catheter body 90. A plurality of resilient biasing members 124 bias the ablation electrodes 122 outwardly toward the expanded arrangement as seen in FIG. 8.

[0044] FIG. 9 illustrates the ablation zones 130 of the ablation elements that span open arc segments around the longitudinal axis of the catheter. Each ablation element has a corresponding ablation zone (130a, 130b, 130c, . . . ). For each ablation element, the ablation zone is a region that is energized with sufficient energy to ablate tissue or denervate nerves within the ablation zone. The ablation zones 130 may be about the same in shape and size as the corresponding ablation elements. For RF electrodes or the like, the ablation zones are likely to be larger than the corresponding RF electrodes. The ablation elements are distributed in a staggered configuration such that the ablation zones 130 of the ablation elements span one or more open arc segments around the longitudinal axis.

[0045] FIG. 10 illustrates the ablation zones 130 of all the ablation elements that, when projected longitudinally onto any lateral plane which is perpendicular to the longitudinal axis, span a closed loop around the longitudinal axis of the catheter. In the embodiment illustrated by FIG. 10, the closed loop is completely closed. In other embodiments, the loop is substantially closed. The substantially closed loop has one or more open portions. The aggregate open portion of the substantially closed loop is about 30 percent or less of the substantially closed loop. An energy source supplies energy to the independently controlled ablation elements simultaneously or sequentially or in an arbitrary order to produce the ablation zones. In this way, tissue ablation or renal denervation or the like can be performed efficiently, effectively, and quickly, and in accordance with user selection.

[0046] In specific embodiments, the ablation electrodes in the expanded arrangement span one or more open arc segments around the longitudinal axis, but all the ablation electrodes in the expanded arrangement projected longitudinally onto any lateral plane which is perpendicular to the longitudinal axis span a substantially closed loop around the longitudinal axis. The substantially closed loop has one or more open portions. The aggregate open portion of the substantially closed loop is about 30 percent or less of the substantially closed loop.

[0047] FIG. 11 illustrates an over-the-wire configuration for introducing the assembly 180 of staggered ablation elements on a catheter to the surgical site by passing a guide wire 200 through an internal lumen of the catheter 182. The guide wire 200 extends through an opening 202 at the distal end of the assembly 180, and through a tube 204 that extends through the assembly 180 to the internal lumen of the catheter 182 from its distal end to its proximal end. The distal end of the assembly 180 is disposed distally of the distal end 184 of the catheter 182.

[0048] FIG. 12 illustrates an over-the-wire configuration for introducing the assembly 190 of staggered ablation elements on a catheter to the surgical site by passing a guide wire 210 through a distal opening 212 provided at the distal end of the assembly 190. The guide wire 210 extends through the distal opening 212 at the distal end of the assembly 190 and partially through a tube 214 with a cut-out or a side or intermediate opening 216, exiting via the cut-out or side/intermediate opening, and further extends externally of the catheter 192 toward the proximal end of the catheter 192. In FIG. 12, both the distal opening 212 and the intermediate opening 216 are disposed distally of the distal end 194 of the catheter 192.

[0049] In the description, numerous details are set forth for purposes of explanation in order to provide a thorough understanding of the present invention. However, it will be apparent to one skilled in the art that not all of these specific details are required in order to practice the present invention. Additionally, while specific embodiments have been illustrated and described in this specification, those of ordinary skill in the art appreciate that any arrangement that is calculated to achieve the same purpose may be substituted for the specific embodiments disclosed. This disclosure is intended to cover any and all adaptations or variations of the present invention, and it is to be understood that the terms used in the following claims should not be construed to limit the invention to the specific embodiments disclosed in the specification. Rather, the scope of the invention is to be determined entirely by the following claims, which are to be construed in accordance with the established doctrines of claim interpretation, along with the full range of equivalents to which such claims are entitled.

Claims

What is claimed is:

1. An ablation catheter comprising:

an elongated catheter body extending longitudinally between a proximal end and a distal end along a longitudinal axis; and

an electrode assembly connected to the catheter body, the electrode assembly comprising a plurality of spines, each of the plurality of spines having a proximal end connected to the catheter body and a distal end, the distal ends of the plurality of spines being connected to a spine distal junction, wherein each of the plurality of spines includes an intermediate segment, a proximal leg coupled between the intermediate segment and the proximal end and a distal leg coupled between the intermediate segment and the distal end, each of the plurality of spines further including a proximal hinge coupled between the proximal leg and the intermediate segment and a distal hinge coupled between the distal leg and the intermediate segment, a proximal stiffness change between the proximal end and the intermediate segment of each of the plurality of spines, and a distal stiffness change between the distal end and the intermediate segment of each of the plurality of spines, wherein each of the plurality of spines include a plurality of ablation electrodes on the intermediate segments, each of the plurality of ablation electrodes is configured to be energized to produce an ablation zone;

wherein the electrode assembly is movable between a collapsed arrangement and an expanded arrangement with the intermediate segments of each of the plurality of spines in the expanded arrangement is configured to move outwardly relative to the proximal ends and distal ends of each of the plurality of spines with respect to the collapsed arrangement; and

wherein the plurality of ablation electodes are distributed on the intermediate segments in a staggered configuration such that the ablation zones of the plurality of ablation electodes span one or more open arc segments around the longitudinal axis, and the ablation zones of all the plurality of ablation electodes projected longitudinally onto any lateral plane which is perpendicular to the longitudinal axis span a substantially closed loop around the longitudinal axis.

2. The ablation catheter of claim 1,

wherein the proximal leg of each of the plurality of spines has a lower stiffness than the intermediate sedment of each of the plurality of spines and the distal leg of each of the plurality of spines has a lower stiffness than the intermediate segment of each of the plurality of spines.

3. The ablation catheter of claim 1,

wherein the proximal leg of each of the plurality of spines is smaller in cross-section than the intermediate segment of each of the plurality of spines and the distal leg of each of the plurality of spines is smaller in cross section than the intermediate segment of each of the plurality of spines.

4. The ablation catheter of claim 1, further comprising

a plurality of temperature sensors thermally coupled with the plurality of ablation electrodes to measure temperatures of the plurality of ablation electrodes.

5. The ablation catheter of claim 1,

wherein the plurality of spines include a plurality of irrigation fluid channels near the plurality of ablation electrodes to direct irrigation fluid toward the plurality of ablation electrodes.

6. The ablation catheter of claim 1,

wherein at least some of the plurality of ablation electrodes have a lateral dimension which is greater than a longitudinal dimension thereof.

7. The ablation catheter of claim 1,

wherein the plurality of ablation electodes in the expanded arrangement are configured to contact surfaces to be ablated; and

wherein the plurality of ablation electrodes in the expanded arrangement are configured to span one or more open arc segments around the longitudinal axis, and all the plurality of ablation electrodes in the expanded arrangement projected longitudinally onto any lateral plane which is perpendicular to the longitudinal axis are configured to span a substantially closed loop around the longitudinal axis.

8. The ablation catheter of claim 1,

wherein at least one of the plurality of spines includes a shape memory material that biases the spine toward the expanded arrangement.

Patent Citations (124)

Patent	Date	Inventor	Cited By
US3650277(A)	1972-03-01	Sjostrand et al.	Applicant
US4658819(A)	1987-04-01	Harris et al.	Applicant
US5035694(A)	1991-07-01	Kasprzyk et al.	Applicant
US5255679(A)	1993-10-01	Imran	Applicant
US5300068(A)	1994-04-01	Rosar et al.	Applicant
US5368591(A)	1994-11-01	Lennox et al.	Applicant
US5387233(A)	1995-02-01	Alferness et al.	Applicant
US5465717(A)	1995-11-01	Imran et al.	Applicant
US5531779(A)	1996-07-01	Dahl et al.	Applicant
US5598848(A)	1997-02-01	Swanson et al.	Applicant
US5607462(A)	1997-03-01	Imran	Applicant
US5628313(A)	1997-05-01	Webster, Jr.	Applicant
US5676662(A)	1997-10-01	Fleischhacker et al.	Applicant
US5707400(A)	1998-01-01	Terry, Jr. et al.	Applicant
US5769077(A)	1998-06-01	Lindegren	Applicant
US5772590(A)	1998-06-01	Webster, Jr.	Applicant
US5893885(A)	1999-04-01	Webster, Jr.	Applicant
US5897553(A)	1999-04-01	Mulier et al.	Applicant
US5954649(A)	1999-09-01	Chia et al.	Applicant
US5954719(A)	1999-09-01	Chen et al.	Applicant
US6004269(A)	1999-12-01	Crowley et al.	Applicant
US6012457(A)	2000-01-01	Lesh	Applicant
US6016437(A)	2000-01-01	Tu et al.	Applicant
US6024740(A)	2000-02-01	Lesh et al.	Applicant
US6073048(A)	2000-06-01	Kieval et al.	Applicant
US6096037(A)	2000-08-01	Mulier et al.	Applicant
US6117101(A)	2000-09-01	Diederich et al.	Applicant
US6161543(A)	2000-12-01	Cox et al.	Applicant
US6178349(B1)	2001-01-01	Kieval	Applicant
US6200312(B1)	2001-03-01	Zikorus et al.	Applicant
US6216044(B1)	2001-04-01	Kordis	Applicant
US6233491(B1)	2001-05-01	Kordis et al.	Applicant
US6283951(B1)	2001-09-01	Flaherty et al.	Applicant
US6287608(B1)	2001-09-01	Levin et al.	Applicant
US6292695(B1)	2001-09-01	Webster, Jr. et al.	Applicant
US6322559(B1)	2001-11-01	Daulton et al.	Applicant
US6460545(B2)	2002-10-01	Kordis	Applicant
US6522926(B1)	2003-02-01	Kieval et al.	Applicant
US6613045(B1)	2003-09-01	Laufer et al.	Applicant
US6616624(B1)	2003-09-01	Kieval	Applicant
US6635054(B2)	2003-10-01	Fjield et al.	Applicant
US6656174(B1)	2003-12-01	Hegde et al.	Applicant
US6669655(B1)	2003-12-01	Acker et al.	Applicant
US6699231(B1)	2004-03-01	Sterman et al.	Applicant
US6748255(B2)	2004-06-01	Fuimaono et al.	Applicant
US6805131(B2)	2004-10-01	Kordis	Applicant
US6845267(B2)	2005-01-01	Harrison et al.	Applicant
US6954977(B2)	2005-10-01	Maguire et al.	Applicant
US6970730(B2)	2005-11-01	Fuimaono et al.	Applicant
US7122031(B2)	2006-10-01	Edwards et al.	Applicant
US7149574(B2)	2006-12-01	Yun et al.	Applicant
US7155284(B1)	2006-12-01	Whitehurst et al.	Applicant
US7162303(B2)	2007-01-01	Levin et al.	Applicant
US7245955(B2)	2007-07-01	Rashidi	Applicant
US7291146(B2)	2007-11-01	Steinke et al.	Applicant
US7363076(B2)	2008-04-01	Yun et al.	Applicant
US7419486(B2)	2008-09-01	Kampa	Applicant
US7465288(B2)	2008-12-01	Dudney et al.	Applicant
US7468062(B2)	2008-12-01	Oral et al.	Applicant
US7481803(B2)	2009-01-01	Kesten et al.	Applicant
US7653438(B2)	2010-01-01	Deem et al.	Applicant
US7717948(B2)	2010-05-01	Demarais et al.	Applicant
US7742795(B2)	2010-06-01	Stone et al.	Applicant
US7850685(B2)	2010-12-01	Kunis et al.	Applicant
US7949407(B2)	2011-05-01	Kaplan et al.	Applicant
US8145316(B2)	2012-03-01	Deem et al.	Applicant
US8224416(B2)	2012-07-01	de la Rama et al.	Applicant
US8343213(B2)	2013-01-01	Salahieh et al.	Applicant
US8347891(B2)	2013-01-01	Demarais et al.	Applicant
US8442639(B2)	2013-05-01	Walker et al.	Applicant
US8454594(B2)	2013-06-01	Demarais et al.	Applicant
US8545495(B2)	2013-10-01	Scheib	Applicant
US2002/0068885(A1)	2002-06-01	Harhen et al.	Applicant
US2002/0120304(A1)	2002-08-01	Mest	Applicant
US2003/0050681(A1)	2003-03-01	Pianca et al.	Applicant
US2003/0060858(A1)	2003-03-01	Kieval et al.	Applicant
US2003/0074039(A1)	2003-04-01	Puskas	Applicant
US2003/0114739(A1)	2003-06-01	Fuimaono et al.	Applicant
US2003/0216792(A1)	2003-11-01	Levin et al.	Applicant
US2003/0233099(A1)	2003-12-01	Danaek et al.	Applicant
US2004/0215186(A1)	2004-10-01	Cornelius et al.	Applicant
US2005/0096647(A1)	2005-05-01	Steinke et al.	Applicant
US2005/0159742(A1)	2005-07-01	Lesh	Examiner
US2005/0288730(A1)	2005-12-01	Deem et al.	Applicant
US2006/0089678(A1)	2006-04-01	Shalev	Applicant
US2007/0135875(A1)	2007-06-01	Demarais et al.	Applicant
US2008/0125772(A1)	2008-05-01	Stone et al.	Applicant
US2008/0255478(A1)	2008-10-01	Burdette	Applicant
US2009/0076409(A1)	2009-03-01	Wu et al.	Applicant
US2010/0016762(A1)	2010-01-01	Thapliyal et al.	Applicant
US2010/0094209(A1)	2010-04-01	Drasler et al.	Applicant
US2010/0168737(A1)	2010-07-01	Grunewald	Applicant
US2010/0249773(A1)	2010-09-01	Clark et al.	Applicant
US2010/0268307(A1)	2010-10-01	Demarais et al.	Applicant
US2010/0286684(A1)	2010-11-01	Hata et al.	Applicant
US2011/0004087(A1)	2011-01-01	Fish et al.	Applicant
US2011/0118726(A1)	2011-05-01	de la Rama et al.	Applicant
US2011/0137298(A1)	2011-06-01	Nguyen et al.	Applicant
US2011/0160720(A1)	2011-06-01	Johnson	Applicant
US2011/0213231(A1)	2011-09-01	Hall et al.	Applicant
US2011/0257641(A1)	2011-10-01	Hastings et al.	Applicant
US2011/0264011(A1)	2011-10-01	Wu et al.	Applicant
US2011/0264086(A1)	2011-10-01	Ingle	Applicant
US2012/0143097(A1)	2012-06-01	Pike, Jr.	Applicant
US2012/0143298(A1)	2012-06-01	Just et al.	Applicant
US2012/0296232(A1)	2012-11-01	Ng	Applicant
US2012/0323233(A1)	2012-12-01	Maguire et al.	Applicant
US2013/0116737(A1)	2013-05-01	Edwards et al.	Applicant
US2013/0131743(A1)	2013-05-01	Yamasaki et al.	Applicant
US2013/0144251(A1)	2013-06-01	Sobotka	Applicant
US2013/0172715(A1)	2013-07-01	Just et al.	Applicant
WO94/22366(A1)	1994-10-01		Applicant
WO97/45157	1997-12-01		Applicant
WO/66020	2000-11-01		Applicant
WO1/00273	2001-01-01		Applicant
WO1/22897	2001-04-01		Applicant
WO2/26314	2002-04-01		Applicant
WO3/082080	2003-10-01		Applicant
WO2006/041881	2006-04-01		Applicant
WO2007/149970	2007-12-01		Applicant
WO2008/141150	2008-11-01		Applicant
WO2008/151001	2008-12-01		Applicant
WO2012/064818	2012-05-01		Applicant
WO2012/106492	2012-08-01		Applicant

Non-Patent Literature (247)

Abboud, Francois M., The Sympathetic System in Hypertension, State-of-the-Art Review, Hypertension Journal of the American Heart Association, Hypertension 4 (suppl II): II-208-II-225, 1982.Applicant
Allen, Edgar V., Sympathectomy for Essential Hypertension, Circulation Journal of the American Heart Association, vol. VI, Jul. 1952, 131-140.Applicant
Anderson, Erling A. et al, Elevated Sympathetic Nerve Activity in Borderline Hypertensive Humans, Evidence From Direct Intraneural Recordings, Hypertension Journal of the American Heart Association, vol. 14, No. 2, Aug. 1989, 177-183.Applicant
Ardian, Inc., Ardian(R) Receives 2010 EuroPCR Innovation Award and Demonstrates Further Durability of Renal Denervation Treatment for Hypertension, PR Newswire, Jun. 3, 2010.Applicant
Arentz, Thomas et al, Feasibility and Safety of Pulmonary Vein Isolation Using a New Mapping and Navigation System in Patients with Refractory Atrial Fibrillation, Circulation Journal of the American Heart Association, Nov. 18, 2003, 2484-2490.Applicant
Badoer, Emilio et al, Cardiac Afferents Play the Dominant Role in Renal Nerve Inhibition Elicited by Volume Expansion in the Rabbit, American Journal of Physiology, 1998, R383-R388.Applicant
Bakris, George L. et al, Baroreflex Activation Therapy Provides Durable Benefit in Patients with Resistant Hypertension: Results of Long-Term Follow-up in the Rheos Pivotal Trial, J Am Soc Hypertens. Mar.-Apr. 2012;6 (2):152-8.Applicant
Bao, Gang et al, Blood Pressure Response to Chronic Episodic Hypoxia: Role of the Sympathetic Nervous System, American Journal of Physiology, 1997, 95-101.Applicant
Barajas, Luciano et al, Anatomy of the Renal Innervation: Intrarenal Aspects and Ganglia of Origin, Canadian Journal of Physiology and Pharmacology, vol. 70, No. 5, May 1992, 735-749.Applicant
Barajas, Luciano et al, Monoaminergic Innervation of the Rat Kidney: A Quantitative Study, American Journal of Physiology, vol. 259, No. 3, Sep. 1990, F503-F511.Applicant
Bardram, Linda et al, Late Results After Surgical Treatment of Renovascular Hypertension, A Follow-up Study of 122 Patients 2-18 Years After Surgery, Annals of Surgery, vol. 201, No. 2, Feb. 1985, 219-224.Applicant
Bello-Reuss, Elsa et al, Effect of Renal Sympathetic Nerve Stimulation on Proximal Water and Sodium Reabsorption, The Journal of Clinical Investigation, vol. 57, Apr. 1976, 1104-1107.Applicant
Bello-Reuss, Elsa et al, Effects of Acute Unilateral Renal Denervation in the Rat, The Journal of Clinical Investigation, vol. 56, Jul. 1975, 208-217.Applicant
Benito, Fernando et al, Radiofrequency Catheter Ablation of Accessory Pathways in Infants, Heart, 1997, 78, 160-162.Applicant
Bernardi, Luciano et al, Influence of Type of Surgery on the Occurrence of Parasympathetic Reinnervation After Cardiac Transplantation, Circulation Journal of The American Heart Association, Apr. 14, 1998;97(14):1368-74.Applicant
Bertog, Stefan C. et al, Renal Denervation for Hypertension, JACC: Cardiovascular Interventions, vol. 5, No. 3, Mar. 2012, 249-258.Applicant
Bertram, Harald et al, Coronary Artery Stenosis After Radiofrequency Catheter Ablation of Accessory Atrioventricular Pathways in Children with Ebstein's Malformation, Circulation Journal of the American Heart Association, 2001, 538-543Applicant
Blankestijn, Peter J. et al, Renal Denervation: Potential Impact on Hypertension in Kidney Disease?, Nephrol Dial Transplant (2011) 0: 1-3.Applicant
Blankestijn, Peter J. et al, Sympathetic Overactivity in Renal Failure Controlled by ACE Inhibition: Clinical Significance, Nephrol Dial Transplant, 2000, 15, 755-758.Applicant
Blum, Ulrich et al, Treatment of Ostial Renal-Artery Stenoses with Vascular Endoprostheses After Unsuccessful Balloon Angioplasty, The New England Journal of Medicine, vol. 336, No. 7, Feb. 1997, 459-465Applicant
Brinkmann, Julia et al, Catheter-Based Renal Nerve Ablation and Centrally Generated Sympathetic Activity in Difficult-to-Control Hypertensive Patients Prospective Case Series, Hypertension. 2012;60:1485-1490.Applicant
Brookes, Linda et al, Renal Denervation: Is Reality Meeting Expectations?, An Interview with Michel Azizi, MD, PhD, Medscape, Jan. 7, 2013.Applicant
Bunte, Matthew C. et al, Endovascular Treatment of Resistant and Uncontrolled Hypertension, JACC: Cardiovascular Interventions, vol. 6, No. 1, 2013, 1-9.Applicant
Calleary, Hickey D. et al, Pre-Transplant Bilateral Native Nephrectomy for Medically Refractory Hypertension, The Irish Medical Journal, Jul.-Aug. 2001;94(7):214-6Applicant
Callens, David J. et al, Narrowing of the Superior Vena Cava-Right Atrium Junction During Radiofrequency Catheter Ablation for Inappropriate Sinus Tachycardia: Analysis with Intracardiac Echocardiography, Journal of the American College of Cardiology, vol. 33, No. 6, 1999, 1667-1670.Applicant
Campese, V.M., Is Hypertension in Chronic Renal Failure Neurogenic in Nature?, Nephrol Dial Transplant, 1994, 9: 741-742.Applicant
Campese, Vito M. et al, Neurogenic Factors in Renal Hypertension, Current Hypertension Reports, 2002 4: 256-260.Applicant
Campese, Vito M. et al, Renal Afferent Denervation Prevents Hypertension in Rats With Chronic Renal Failure, Hypertension, 1995, 25, 878-882.Applicant
Campese, Vito M. et al, Renal Afferent Denervation Prevents the Progression of Renal Disease in the Renal Ablation Model of Chronic Renal Failure in Rat, American Journal of Kidney Disease, vol. 26, No. 5, Nov. 1995, 861-865.Applicant
Campese, Vito M., Interventional Hypertension: A New Hope or a New Hype? The Need to Redefine Resistant Hypertension, J Hypertens. Nov. 2013;31(11):2118-21.Applicant
Canadian Agency for Drugs and Technologies in Health, Catheter-Based Renal Denervation for Treatment-Resistant Hypertension; Issues in Emerging Health Technologies, Issue 121, Mar. 2013.Applicant
Carlstedt, Thomas et al, Regrowth of Lesioned Dorsal Root Nerve Fibers into the Spinal Cord of Neonatal Rats, Neuroscience Letters Feb. 10, 1987;74(1):14-8.Applicant
Chabanier, H. et al, On the Decapsulation and Neurectomy of the Kidnesy in Permanent Hypertensive States, The Medical Press, Feb. 22, 1936, No. 16, 307-310.Applicant
Ciccone, C D et al, Effects of Acute Renal Denervation on Kidney Function in Deoxycorticosterone Acetate-Hypertensive Swine, Hypertension Journal of the American Heart Association, Oct. 1986, vol. 8, No. 10, 925-931.Applicant
Ciriello, John et al, Renal Afferents and Hypertension, Current Hypertension Reports 2002, 4:136-142.Applicant
Converse, Richard L. et al, Sympathetic Overactivity in Patients with Chronic Renal Failure, The New England Journal of Medicine, vol. 327, No. 27, 1992, 1912-1918.Applicant
Crile, George, The Clinical Results of Celiac Ganglionectomy in the Treatment of Essential Hypertension, Annals of Surgery, Jun. 1938; 107(6): 909-916.Applicant
Cruickshank, J.M., Beta-Blockers Continue to Surprise Us, European Heart Journal (2000) 21, 354-364.Applicant
Curtis, John J. et al, Surgical Therapy for Persistent Hypertension After Renal Transplantation, Transplantation, vol. 31, No. 2, 1981, 125-128.Applicant
Dailey, U.G., Surgical Treatment of Hypertension: A Review-Part II, Journal of the National Medical Association, May 1948, vol. 40, No. 3., 113-116.Applicant
Dailey, U.G., Surgical Treatment of Hypertension: A Review-Part III, Journal of the National Medical Association, Jul. 1948, vol. 40, No. 4, 160-162.Applicant
Dailey, U.G., The Surgical Treatment of Hypertension: A Review, Journal of the National Medical Association, Mar. 1948, vol. 40, No. 2, 76-79.Applicant
Davis, Mark I. et al, Effectiveness of Renal Denervation Therapy for Resistant Hypertension a Systematic Review and Meta-Analysis, Journal of the American College of Cardiology, vol. 62, No. 3, 2013, 231-241.Applicant
De Wardener, H.E., The Hypothalamus and Hypertension, Physiological Reviews,vol. 81, No. 4, Oct. 2001.Applicant
Dequattro V. et al, The Sympathetic Nervous System: The Muse of Primary Hypertension, Journal of Human Hypertension, 2002, 16 (Suppl 1), S64-S69.Applicant
Dibona, Gerald F. et al, Neural Control of Renal Function, Physiological Reviews, vol. 77, No. 1, Jan. 1997, 75-197.Applicant
Dibona, Gerald F. et al, Translational Medicine: The Antihypertensive Effect of Renal Denervation, Americal Journal of Physiology, 2010, 298, R245-R253.Applicant
Dibona, Gerald F., Neural Control of Renal Function: Cardiovascular Implications, Hypertension Journal of The American Heart Association, vol. 13, No. 6, Part 1, Jun. 1989, 539-548.Applicant
Dibona, Gerald F., Neural Control of the Kidney: Functionally Specific Renal Sympathetic Nerve Fibers, American Journal of Physiology, 2000, 279, R1517-R1524.Applicant
Dibona, Gerald F., Neural Control of the Kidney: Past, Present, and Future, Hypertension Journal of the American Heart Association, vol. 41, Mar. 2003, Part II, 621-624.Applicant
Dibona, Gerald F., Renal Innervation and Denervation: Lessons from Renal Transplantation Reconsidered, Artificial Organs, vol. 11, No. 6, 1987, 457-462.Applicant
Dibona, Gerald F., Role of the Renal Nerves in Renal Sodium Retention and Edema Formation, Trans Am Clin Climatol Assoc. 1990; 101: 38-45.Applicant
Dibona, Gerald F., Sympathetic Nervous System and Hypertension, Hypertension Journal of The American Heart Association, 2013; 61: 556-560.Applicant
Dibona, Gerald F., Sympathetic Nervous System and the Kidney in Hypertension, Curr Opin Nephrol Hypertens. Mar. 2002;11(2):197-200.Applicant
Dibona, Gerald F., The Sympathetic Nervous System and Hypertension, Hypertension Journal of The American Heart Association, Vo. 43, Feb. 2004, 147-150.Applicant
Doumas, Michael et al, Interventional Management of Resistant Hypertension, The Lancet, vol. 373, Apr. 11, 2009, pp. 1228-1230.Applicant
Dubuc, Marc et al, Feasibility of Cardiac Cryoablation Using a Transvenous Steerable Electrode Catheter, Journal of Interventional Cardiac Electrophysiology, 1998, 2: 285-292.Applicant
Elmula, Fadl et al, Renal Sympathetic Denervation in Patients With Treatment-Resistant Hypertension After Witnessed Intake of Medication Before Qualifying Ambulatory Blood Pressure, Hypertension. 2013;62:526-532.Applicant
Esler, M. et al, Sympathetic Nerve Activity and Neurotransmitter Release in Humans: Translation from Pathophysiology into Clinical Practice, Scandinavian Physiological Society, 2003, 177, 275-284.Applicant
Esler, Murray D. et al, Renal Sympathetic Denervation in Patients with Treatment-Resistant Hypertension (The Symplicity HTN-2 Trial): A Randomised Controlled Trial, Lancet, 2010; 376:1903-1909.Applicant
Esler, Murray et al, Assessment of Human Sympathetic Nervous System Activity from Measurements of Norepinephrine Turnover, Hypertension Journal of the American Heart Association, vol. 11, No. 1, Jan. 1988, 3-20.Applicant
Evelyn, Kenneth A. et al, Effect of Thoracolumbar Sympathectomy on the Clinical Course of Primary (Essential) Hypertension, American Journal of Medicine, Feb. 1960, 188-221.Applicant
Freyberg, R. H. et al, The Effect on the Kidney of Bilateral Splanchnicectomy in Patients with Hypertension, The Journal of Clinical Investigation, vol. 16, Issue 1, Jan. 1937, 49-65.Applicant
Gafoor, Sameer et al, Nonresponders to Renal Denervation for Resistant Hypertension, Endovascular Today, Oct. 2013, 63-70.Applicant
Garel, L. et al, Fatal Outcome After Ethanol Renal Ablation in Child with End-Stage Kidneys; AJR 146:593-594, Mar. 1986.Applicant
Gazdar, A. F. et al, Neural Degeneration and Regeneration in Human Renal Transplants, The New England Journal of Medicine, vol. 238, No. 5, Jul. 1970, 222-224.Applicant
Goldberg, Michael R. et al, Reconstructive Vascular Surgery for Renovascular Hypertension, Can Med Assoc J. Feb. 2, 1974;110(3):275-80.Applicant
Golwyn, Daniel H. et al, Percutaneous Transcatheter Renal Ablation with Absolute Ethanol for Uncontrolled Hypertension or Nephrotic Syndrome: Results in 11 Patients with End-Stage Renal Disease, Journal of Vascular and Interventional Radiology, Jul.-Aug. 1997, vol. 8, No. 4, 527-533.Applicant
Gorisch, Wolfram et al, Heat-Induced Contraction of Blood Vessels, Lasers in Surgery and Medicine 2:1-13 (1982).Applicant
Grassi, Guido et al, Baroreflex Control of Sympathetic Nerve Activity in Essential and Secondary Hypertension, Hypertension Journal of The American Heart Association, 1998;31:68-72.Applicant
Grassi, Guido et al, Dissociation Between Muscle and Skin Sympathetic Nerve Activity in Essential Hypertension, Obesity, and Congestive Heart Failure, Hypertension. 1998;31:64-67.Applicant
Grimson, Keith S. et al, Results of Treatment of Patients with Hypertension by Total Thoracic and Partial to Total Lumbar Sympathectomy, Splanchnicectomy and Celiac Ganglionectomy, Annals of Surgery, Jun. 1949, vol. 129, No. 6, 850-871.Applicant
Grimson, Keith S. et al, Total Thoracic and Partial to Total Lumbar Sympathectomy, Splanchnicectomy and Celiac Ganglionectomy for Hypertension, Annals of Surgery, Oct. 1953, vol. 138, No. 4, 532-547.Applicant
Grimson, Keith S., Total Thoracic and Partial to Total Lumbar Sympathectomy and Celiac Ganglionectomy in the Treatment of Hypertension, Annals of Surgery, Oct. 1941, vol. 114, No. 4, 753-775.Applicant
Guyton, Arthur C., Blood Pressure Control Special Role of the Kidneys and Body Fluids, Science, vol. 252, Jun. 1991, 1813-1816.Applicant
Hafkenschiel, Joseph H. et al, Primary Hypertension Survey of the Survival of Patients with Established Diastolic Hypertension After Ten Years of Medical and Surgical Treatment, The American Journal of Cardiology, vol. 16, Jul. 1965, 61-66.Applicant
Hafkenschiel, Joseph H. et al, The Surgical Treatment of Hypertension with Particular Reference to Andrenalectomy and Sympathectomy, Transactions. American College of Cardiology, vol. 5, Dec. 1955, pp. 107-112.Applicant
Hall, J.E. et al, Role of Sympathetic Nervous System and Neuropeptides in Obesity Hypertension, Brazilian Journal of Medical and Biological Research, 2000, 33:605-618.Applicant
Hall, John E., The Kidney, Hypertension, and Obesity, Hypertension. 2003;41:625-633.Applicant
Hall, Winthrop H. et al, Combined Embolization and Percutaneous Radiofrequency Ablation of a Solid Renal Tumor, American Journal of Roentgenology, 174, Jun. 2000, 1592-1594.Applicant
Hamm, Christian et al, Confluence, Issue eight, Apr. 2014.Applicant
Han, Young-Min et al, Renal Artery Embolization with Diluted Hot Contrast Medium: An Experimental Study, Journal of Vascular and Interventional Radiology, Jul. 2001;12(7):862-868.Applicant
Hansen, Jesper Melchoir et al, The Transplanted Human Kidney Does Not Achieve Functional Reinnervation, Clinical Science, (1994) 87, 13-20.Applicant
Heuer, George J., The Surgical Treatment of Essential Hypertension, Annals of Surgery, Oct. 1936, vol. 104, No. 3, 771-786.Applicant
Hinton, J. William, End Results of Thoracolumbar Sympathectomy for Advanced Essential Hypertension, The Bulletin, Apr. 1948, 239-252.Applicant
Holmer, Stephan et al, Role of Renal Nerves for the Expression of Renin in Adult Rat Kidney, The American Journal of Physiology, May 1994;266(5 Pt 2):F738-F745.Applicant
Hoobler, S.W. et al, The Effects of Splanchnicectomy on the Blood Pressure in Hypertension, Circulation Journal of The American Heart Association, vol. IV, Aug. 1951, 173-183.Applicant
Hoppe, Uta C. et al, Minimally Invasive System for Baroreflex Activation Therapy Chronically Lowers Blood Pressure with Pacemaker-like Safety Profile: Results from the Barostim Neo Ttrial, J Am Soc Hypertens. Jul.-Aug. 2012;6 (4):270-6.Applicant
Howard, James P. et al, Size of Blood Pressure Reduction from Renal Denervation: Insights from Meta-Analysis of Antihypertensive Drug Trials of 4121 Patients with Focus on Trial Design: the Converge Report, Heart 2013;0:1-9.Applicant
Howard, James P. et al, Unintentional Overestimation of an Expected Antihypertensive Effect in Drug and Device Trials: Mechanisms and Solutions, International Journal of Cardiology, vol. 172, Issue 1, Mar. 1, 2014, pp. 29-35.Applicant
Howell, Marcus H. et al, Tandem Stenting of Crossed Renal Arteries with Ostial Stenosis, Tex Heart Inst J. 2000; 27(2): 166-169.Applicant
Hoye, Neil A. et al, Endovascular Renal Denervation: A Novel Sympatholytic with Relevance to Chronic Kidney Disease, Clinical Kidney Journal Advance Access, (2013) 0: 1-8.Applicant
Huang, Shoei K. Stephen et al, Radiofrequency Catheter Ablation of Cardiac Arrhythmias, Basic Concepts and Clinical Applications, Wiley-Blackwell, Jun. 2000, 1-12.Applicant
Huang, Wann-Chu, Renal Denervation Prevents and Reverses Hyperinsulinemia-Induced Hypertension in Rats, Hypertension Journal of The American Heart Association, 1998;32:249-254.Applicant
Humpreys, Michael H., Renal Nerves and CKD: Is Renal Denervation the Answer?, Journal of The American Socity of Nephrology, 2012, 23: 1-3.Applicant
Irigoyen, M.C.C. et al, Baroreflex Control of Sympathetic Activity in Experimental Hypertension, Brazilian Journal of Medical and Biological Research, (1998) 31: 1213-1220.Applicant
Izzo, Jr, Joseph L. et al, The Sympathetic Nervous System and Baroreflexes in Hypertension and Hypotension, Current Hypertension Reports 1999, 3:254-263.Applicant
Jackman, Warren M. et al, Catheter Ablation of Arrhythmias, Proposed Anatomy and Catheter Ablation of Epicardial Posteroseptal and Left Posterior Accessory AV Pathways (Chapter 16), 2002, Futura Publishing Company, Inc., 321-343.Applicant
Moak, Jeffrey P. et al, Case Report: Pulmonary Vein Stenosis Following RF Ablation of Paroxysmal Atrial Fibrillation: Successful Treatment with Balloon Dilation, Journal of Interventional Cardiac Electrophysiology, Dec. 2000, 4, 4:621-631.Applicant
Mogil, Robert A. et al, Renal Innervation and Renin Activity in Salt Metabolism and Hypertension, American Journal of Physiology, vol. 216, No. 4, Apr. 1969, 693-697.Applicant
Morita, Hironobu et al, Neural Control of Urinary Sodium Excretion During Hypertonic NaC1 Load in Conscious Rabbits: Role of Renal and Hepatic Nerves and Baroreceptors, Journal of the Autonomic Nervous System, 34 (1991) 157-170.Applicant
Morrissey, D.M. et al, Sympathectomy in the Treatment of Hypertension, The Lancet, Feb. 1953, 403-408.Applicant
Mortara, Andrea et al, Nonselective Beta-Adrenergic Blocking Agent, Carvedilol, Improves Arterial Baroflex Gain and Heart Rate Variability in Patients With Stable Chronic Heart Failure, Journal of the American College of Cardiology, vol. 36, No. 5, 2000, 1612-1618.Applicant
Moss, Jonathan, Interventional Radiology and Renal Denervation, Interventions, vol. 13, Issue 3, 2013.Applicant
Naghavi, Morteza et al, Thermography Basket Catheter: In Vivo Measurement of the Temperature of Atherosclerotic Plaques for Detection of Vulnerable Plaques, Catheterization and Cardiovascular Interventions 59:52-59 (2003).Applicant
Naidoo, N. et al, Thoracic Splanchnic Nerves: Implications for Splanchnic Denervation, Journal of Anatomy, Nov. 2001;199(Pt 5):585-590.Applicant
Nakagawa, A. et al, Selective Ablation of Porcine and Rabbit Liver Tissue Using Radiofrequency: Preclinical Study, European Surgical Research, 1999;31:371-379.Applicant
Nakagawa, Hiroshi et al, Inverse Relationship Between Electrode Size and Lesion Size During Radiofrequency Ablation With Active Electrode Cooling, Circulation. Aug. 4, 1998;98(5):458-465.Applicant
Nanni, Gregg S. et al, Control of Hypertension by Ethanol Renal Ablation, Radiology 148: 51-54, Jul. 1983.Applicant
Ndegwa, S., Catheter-Based Renal Denervation for Treatment-Resistant Hypertension [Issues in emerging health technologies issue 121]. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2013.Applicant
Neutel, Joel M., Hypertension and Its Management: A Problem in Need of New Treatment Strategies, Journal of Renin-Angiotensin-Aldosterone System 2000 1: S10-S13.Applicant
Newcombe, C.P. et al, Sympathectomy for Hypertension, British Medical Journal, Jan. 1959, 142-144.Applicant
Ng, Fu Siong et al, Catheter Ablation of Atrial Fibrillation, Clinical Cardiology, 25, 384-394 (2002).Applicant
Norman, Roger A. et al, Role of the Renal Nerves in One-Kidney, One Clip Hypertension in Rats, Hypertension Journal of The American Heart Association, 1984;6:622-626.Applicant
Nozawa, Takashi et al, Effects of Long-Term Renal Sympathetic Denervation on Heart Failure After Myocardial Infarction in Rats, Heart Vessels (2002) 16:51-56.Applicant
O'Connor, Brian K. et al, Radiofrequency Ablation of a Posteroseptal Accessory Pathway Via the Middle Cardiac Vein in a Six-Year-Old Child, PACE, vol. 20, Oct. 1997, Part 1, 2504-2507.Applicant
O'Hagen, Kathleen P. et al, Renal Denervation Decreases Blood Pressure in DOCA-Treated Miniature Swine With Established Hypertension, American Journal of Hypertension, 1990; 3:62-64.Applicant
Oliveira, Vera L.L. et al, Renal Denervation Normalizes Pressure and Baroreceptor Reflex in High Renin Hypertension in Conscious Rats, Hypertension vol. 19, No. 2 Feb. 2, 1992, Supplement II, II-17-II-21.Applicant
Omran, Heyder et al, Echocardiographic Imaging of Coronary Sinus Diverticula and Middle Cardiac Veins in Patients with Preexcitation Syndrome: Impact—on Radiofrequency Catheter Ablation of Posteroseptal Accessory Pathways, PACE, vol. 18, Jun. 1995, 1236-1243.Applicant
Oparil, Suzanne et al, Renal Nerve Ablation: Emerging Role in Therapeutics; Blood Pressure, Oct. 2011, vol. 20, No. 5 , pp. 253-255.Applicant
Oral, Hakan et al, Pulmonary Vein Isolation for Paroxysmal and Persistent Atrial Fibrillation, Circulation Journal of The American Heart Association, 2002;105:1077-1081.Applicant
Osborn, Jeffrey L. et al, Long-Term Increases in Renal Sympathetic Nerve Activity and Hypertension, Clinical and Experimental Pharmacology and Physiology (1997) 24,72-76.Applicant
Osborn, John W., The Sympathetic Nervous System and Long-Term Regulation of Arterial Pressure: What Are the Critical Questions?, Clinical and Experimental Pharmacology and Physiology (1997) 24, 68-71.Applicant
Ou, Baiqing et al, Baroreflex Sensitivity Predicts the Induction of Ventricular Arrhythmias by Cesium Chloride in Rabbits, Japanese Circulation Journal, 1999; 63: 783-788.Applicant
Oz, Mehmet, Pressure Relief, TIME Magazine, Monday, Jan. 9, 2012.Applicant
Page, Irvine H. et al, Mechanisms, Diagnosis and Treatment of Hypertension of Renal Vascular Origin, Annal of Internal Medicine, Aug. 1959, vol. 51, No. 2, 196-211.Applicant
Page, Irvine H. et al, Mechanisms, Diagnosis and Treatment of Hypertension of Renal Vascular Origin; Annals of Internal Medicine, Aug. 1959;51:196-211.Applicant
Page, Irvine H. et al, The Effect of Renal Denervation on the Level of Arterial Blood Pressure and Renal Function in Essential Hypertension, Journal of Clinical Investigation, 1935;14(1):27-30.Applicant
Page, Irvine H. et al, The Effects of Renal Denervation on Patients Suffering from Nephritis, J Clin Invest. 1935;14 (4):443-458.Applicant
Page, Irvine H., The Effect of Renal Efficiency of Lowering Arterial Blood Pressure in Cases of Essential Hypertension and Nephritis, Journal of Clinical Investigation, Nov. 1934; 13(6): 909-915.Applicant
Page, Max, Section of Surgery, Discussion on the Surgical Treatment of Hypertension, Proceedings of the Royal Society of Medicine, vol. XLI, Feb. 1948, 359-372.Applicant
Papademetriou, Vasilios, Hypertension and the Simplicity Renal Denervation System, Scientific Background, www.medtronic.com, 2011.Applicant
Pappone, Carlo et al, Circumferential Radiofrequency Ablation of Pulmonary Vein Ostia: A New Anatomic Approach for Curing Atrial Fibrillation, Circulation, Journal of The American Heart Association, 2000;102:2619-2628.Applicant
Parati, Gianfranco et al, The Human Sympathetic Nervous System: Its Relevance in Hypertension and Heart Failure, European Heart Journal (2012) 33, 1058-1066.Applicant
Parmar, Arundhati, Analyst: Medtronic Will Likely Acquire Another Hypertension Therapy Firm, Medcity News, Apr. 27, 2012; 3:06 p.m.; medcitynews.com.Applicant
Pavlovich, Christian P. et al, Percutaneous Radio Requency Ablation of Small Renal Tumors: Initial Results; The Journal of Urology, vol. 167, Jan. 10-15, 2002.Applicant
Peet, Max Minor, Hypertension and Its Surgical Treatment by Bilateral Supradiaphragmatic Splanchnicectomy, American Journal of Surgery, vol. 75, Issue 1, Jan. 1948, 48-68.Applicant
Perry, C. Bruce, Malignant Hypertension Cured by Unilateral Nephrectomy, British Heart Journal, Jul. 1945; 7(3): 139-142.Applicant
Persu, Alexandre et al, Renal Denervation: Ultima Ratio or Standard in Treatment-Resistant Hypertension, Hypertension Journal of The American Heart Association, Sep. 2012;60(3):596-606.Applicant
Peterson, Helen Hogh et al, Lesion Dimensions During Temperature-Controlled Radiofrequency Catheter Ablation of Left Ventricular Porcine Myocardium Impact of Ablation Site, Electrode Size, and Convective Cooling, Circulation Journal of The American Heart Association, 1999;99:319-325.Applicant
Plouin, Pierre-Francois et al, Blood Pressure Outcome of Angioplasty in Atherosclerotic Renal Artery Stenosis a Randomized Trial, Hypertension Journal of The American Heart Association, 1998;31:823-829.Applicant
Poutasse, Eugene F., Surgical Treatment of Renal Hypertension, American Journal of Surgery, vol. 107, Jan. 1964, 97-103.Applicant
Pugsley, M.K. et al, The Vascular System an Overview of Structure and Function, Journal of Pharmacological and Toxicological Methods 44 (2000) 333-340.Applicant
Putney, John Paul, Are Secondary Considerations Still “Secondary”?:An Examination of Objective Indicia of Nonobviousness Five Years After KSR, Intellectual Property Brief, vol. 4, Issue 2, Article 5, 2012, 45-59.Applicant
Ramsay, Lawrence E. et al, Blood Pressure Response to Percutaneous Transluminal Angioplasty for Renovascular Hypertension: An Overview of Published Series; British Medical Journal Mar. 3, 1990; 300(6724): 569-572.Applicant
Rippy, Marian K. et al, Catheter-Based Renal Sympathetic Denervation: Chronic Preclinical Evidence for Renal Artery Safety, Clin Res Cardiol (2011) 100:1095-1101.Applicant
Ritz, Eberhard, New Approaches to Pathogenesis and Management of Hypertension, Clin J Am Soc Nephrol 4: 1886-1891, 2009.Applicant
Zazgornik, Jan et al, Bilateral Nephrectomy: The Best, but Often Overlooked, Treatment for Refractory Hypertension in Hemodialysis Patients, AJH 1998; 11:1364-1370.Applicant
Jaff, Michael R. et al, Kidney Stenting Lowers Blood Pressure in Patients with Severe Hypertension; Catheterization and Cardiovascular Interventions; Published Online: Jun. 27, 2012 (DOI: 10.1002/ccd.24449); Print Issue Date: Sep. 2012. URL: http://onlinelibrary.wiley.com/doi/10.1002/ccd.24449/abstract.Applicant
Jain, Mudit K. et al, A Three-Dimensional Finite Element Model of Radiofrequency Ablation with Blood Flow and Its Experimental Validation, Annals of Biomedical Engineering, vol. 28, pp. 1075-1084, 2000.Applicant
Jais, Pierre et al, Efficacy and Safety of Septal and Left-Atrial Linear Ablation for Atrial Fibrillation, The American Journal of Cardiology, vol. 84 (9A), Nov. 1999, 139R-146R.Applicant
Janssen, Ben J.A. et al, Frequency-Dependent Modulation of Renal Blood Flow by Renal Nerve Activity in Conscious Rabbits, American Journal of Physiology, 1997, 273:R597-R608.Applicant
Janssen, Ben J.A. et al, Renal Nerves in Hypertension, Miner Electrolyte Metab 1989;15:74-82.Applicant
Jin, Yu et al, No Support for Renal Denervation in a Meta-Analysis, JACC vol. 62, No. 21, 2013 Correspondence Nov. 19/26, 2013:2029-30.Applicant
Kaltenbach, Benjamin et al, Renal Artery Stenosis After Renal Sympathetic Denervation, J Am Coll Cardiol. Dec. 25, 2012;60(25):2694-5.Applicant
Kaltenbach, Benjamin et al, Renal Sympathetic Denervation as Second-Line Therapy in Mild Resistant Hypertension: A Pilot Study, Catheterization and Cardiovascular Interventions 81:335-339 (2013).Applicant
Kamiya, Atsunori et al, Parallel Resetting of Arterial Baroreflex Control of Renal and Cardiac Sympathetic Nerve Activities During Upright Tilt in Rabbits, Am J Physiol Heart Circ Physiol 298: H1966-H1975, 2010.Applicant
Kandzari, David E. et al, Catheter-Based Renal Denervation for Resistant Hypertension: Rationale and Design of the Symplicity HTN-3 Trial, Clin. Cardiol. 35, 9, 528-535 (2012).Applicant
Kapural, Leonardo et al, Radiofrequency Ablation for Chronic Pain Control, Current Pain and Headache Reports 2001, 5:517-525.Applicant
Kassab, Salah et al, Renal Denervation Attenuates the Sodium Retention and Hypertension Associated with Obesity, Hypertension vol. 25, No. 4, Part 2 Apr. 1995.Applicant
Katholi, Richard E. et al, Decrease in Peripheral Sympathetic Nervous System Activity following Renal Denervation or Unclipping in the One-Kidney One-Clip Goldblatt Hypertensive Rat, The Journal of Clinical Investigation, Jan. 1982;69(1):55-62.Applicant
Katholi, Richard E. et al, Role of the Renal Nerves in the Pathogenesis of One-Kidney Renal Hypertension in the Rat, Hypertension. 1981;3:404-409.Applicant
Katholi, Richard E. et al, The Role of Renal Sympathetic Nerves in Hypertension: Has Percutaneous Renal Denervation Refocused Attention on Their Clinical Significance?; Progress in Cardiovascular Disease 52 (2009) 243-248.Applicant
Katritsis, Demosthenes et al, Recurrence of Left Atrium-Pulmonary Vein Conduction Following Successful Disconnection in Asymptomatic Patients, Europace (2004) 6, 425e432.Applicant
Killip III, Thomas, Oscillation of Blood Flow and Vascular Resistance During Mayer Waves, Circulation Research, vol. XI, Dec. 1962, 987-993.Applicant
Kingwell, Bronwyn A. et al, Assessment of Gain of Tachycardia and Bradycardia Responses of Cardiac Baroreflex, Am J Physiol Heart Circ Physiol 260:H1254-H1263, 1991.Applicant
Kirchheim, H. et al, Sympathetic Modulation of Renal Hemodynamics, Renin Release and Sodium Excretion, Klin Wochenschr (1989) 67: 858-864.Applicant
Klein, Ge et al, Endovascular Treatment of Renal Artery Aneurysms with Conventional Non-Detachable Microcoils and Guglielmi Detachable Coils, Br J Urol. Jun. 1997; 79(6):852-860.Applicant
Knight, Eric L. et al, Predictors of Decreased Renal Function in Patients with Heart Failure During Angiotensin-Converting Enzyme Inhibitor Therapy: Results from the Studies of Left Ventricular Dysfunction (SOLVD), American Heart Journal, vol. 138, No. 5, Part 1, Nov. 1999, 849-855.Applicant
Koepke, John P. et al, Functions of the Renal Nerves, The Physiologist, vol. 28, No. 1, Feb. 1985, 47-52.Applicant
Kompanowska-Jezierska, Elzbieta et al, Early Effects of Renal Denervation in the Anaesthetised Rat: Natriuresis and Increased Cortical Blood Flow, Journal of Physiology (2001), 531.2, pp. 527-534.Applicant
Krum, Henry et al, Catheter-Based Renal Sympathetic Denervation for Resistant Hypertension: A Multicentre Safety and Proof-of-Principle Cohort Study, www.thelancet.com vol. 373 Apr. 11, 2009 1275-1281.Applicant
Krum, Henry et al, Device-Based Antihypertensive Therapy: Therapeutic Modulation of the Autonomic Nervous System, Circulation. 2011;123:209-215.Applicant
La Grange, Ronald G. et al, Selective Stimulation of Renal Nerves in the Anesthetized Dog: Effect on Renin Release During Controlled Changes in Renal Hemodynamics, Circulation Research, Journal of The American Heart Association, 1973;33:704-712.Applicant
Labeit, Alexander Michael et al, Changes in the Prevalence, Treatment and Control of Hypertension in Germany? A Clinical-Epidemiological Study of 50.000 Primary Care Patients, PLOS ONE, Dec. 2012, vol. 7, Issue 12, e52229, 1-11.Applicant
Labonte, Sylvain, Numerical Model for Radio-Frequency Ablation of the Endocardium and its Experimental Validation, IEEE Transactions on Biomedical Engineering, vol. 41, No. 2. Feb. 1994, 108-115.Applicant
Lambert, Gavin W. et al, Health-Related Quality of Life After Renal Denervation in Patients With Treatment-Resistant Hypertension, Hypertension. 2012;60:1479-1484.Applicant
Lee, Sang Joon et al, Ultrasonic Energy in Endoscopic Surgery, Yonsei Medical Journal, vol. 40, No. 6, pp. 545-549, 1999.Applicant
Leertouwer, Trude C. et al, In-Vitro Validation, with Histology, of Intravascular Ultrasound in Renal Arteries, Journal of Hypertension 1999, vol. 17 No. 2, 271-277.Applicant
Leishman, A.W.D., Hypertension—Treated and Untreated, British Medical Journal, May 1959, 1361-1368.Applicant
Leonard, Bridget L. et al, Differential Regulation of the Oscillations in Sympathetic Nerve Activity and Renal Blood Flow Following Volume Expansion, Autonomic Neuroscience: Basic and Clinical 83 (2000) 19-28.Applicant
Levin, Stephen, Ardian: Succeeding Where Drugs Fail Treating Hypertension in the Cath Lab, In Vivo: The Business & Medicine Report, vol. 27, No. 10, Nov. 2009.Applicant
Litynski, Grzegorz S., Kurt Semm and the Fight against Skepticism: Endoscopic Hemostasis, Laparoscopic Appendectomy, and Semm's Impact on the “Laparoscopic Revolution”, JSLS. Jul.-Sep. 1998; 2(3): 309-313.Applicant
Lu, David S.K. et al, Effect of Vessel Size on Creation of Hepatic Radiofrequency Lesions in Pigs: Assessment of the “Heat Sink” Effect, American Journal of Radiology, 178, Jan. 2002, 47-51.Applicant
Luscher, Thomas F. et al, Renal Nerve Ablation After Symplicity HTN-3: Confused at the Higher Level?; European Heart Journal, doi:10.1093/eurheartj/ehu195; May 14, 2014.Applicant
Lustgarten, Daniel L. et al, Cryothermal Ablation: Mechanism of Tissue Injury and Current Experience in the Treatment of Tachyarrhythmias, Progress in Cardiovascular Diseases, vol. 41, No. 6 May/Jun. 1999: pp. 481-498.Applicant
Mahfoud, Felix et al, Expert Consensus Document from the European Society of Cardiology on Catheter-Based Renal Denervation, European Heart Journal, Jul. 2013;34(28):2149-57.Applicant
Mancia, Giuseppe et al, Sympathetic Activation in the Pathogenesis of Hypertension and Progression of Organ Damage, Hypertension Journal of The American Heart Association, 1999, 34:724-728.Applicant
McGahan, John P. et al, History of Ablation, Tumor Ablation, 2005, pp. 3-16.Applicant
Medtronic, Inc., J.P. Morgan Healthcare Conference, Corrected Transcript, Jan. 13, 2014, Factset:Callstreet, www.callstreet.com.Applicant
Medtronic, Inc., Medtronic Announces U.S. Renal Denervation Pivotal Trial Fails to Meet Primary Efficacy Endpoint While Meeting Primary Safety Endpoint, www.medtronic.com, Jan. 9, 2014.Applicant
Medtronic, Inc., RDN Therapy with the Symplicity Renal Denervation System, Procedure Fact Sheet, www.medtronic.com, 2011.Applicant
Medtronic, Inc., Renal Denervation (RDN) Novel Catheter -based Treatment for Hypertension, Symplicity RDN System Common Q&A, 2011.Applicant
Medtronic, Inc., Scientific Basis Behind Renal Denervation for the Control of Hypertension, Dec. 2012, http://www.icimeeting.com/2012/images/stories/PDF/1448—Wilcox—I—Mon.pdf.Applicant
Mehdirad, Ali et al, Temperature Controlled RF Ablation in Canine Ventricle and Coronary Sinus using 7 Fr or 5 Fr Ablation Electrodes, PACE, vol. 21, Jan. 1998, Part II, 316-321.Applicant
Meredith, I T et al, Exercise Training Lowers Resting Renal But Not Cardiac Sympathetic Activity in Humans; Hypertension Journal of The American Heart Association, 1991;18:575-582.Applicant
Michaelis, Lawrence L. et al, Effects of Renal Denervation and Renin Depletion on the Renal Responses to Intravascular Volume Expansion, Ann Surg. Mar. 1972; 175(3): 424-430.Applicant
Millard, F.C. et al, Renal Embolization for Ablation of Function in Renal Failure and Hypertension, Postgraduate Medical Journal (1989) 65, 729-734.Applicant
Robbins, Ivan M. et al, Pulmonary Vein Stenosis After Catheter Ablation of Atrial Fibrillation, Circulation Journal of The American Heart Association, 1998;98:1769-1775.Applicant
Rocha-Singh, Krishna J., Catheter-Based Sympathetic Renal Denervation a Novel Strategy for the Treatment of Resistant Hypertension, Endovascular Today, Aug. 2009, 52-56.Applicant
Rocha-Singh, Krishna J., Renal Artery Denervation: A Brave New Frontier, Endovascular Today, Feb. 2012, 45-53.Applicant
Sanderson, John E. et al, Effect of B-Blockade on Baroreceptor and Autonomic Function in Heart Failure, Clinical Science (1999) 96, 137-146.Applicant
Santos, Mario et al, Renal Sympathetic Denervation in Resistant Hypertension, World J Cardiol Apr. 26, 2013; 5(4): 94-101.Applicant
Savard, Sebastien et al, Eligibility for Renal Denervation in Patients With Resistant Hypertension When Enthusiasm Meets Reality in Real-Life Patients, J Am Coll Cardiol. 2012;60(23):2422-2424.Applicant
Schauerte, Patrick et al, Catheter Ablation of Cardiac Autonomic Nerves for Prevention of Vagal Atrial Fibrillation, Circulation Journal of The American Heart Association, 2000, 102:2774-2780.Applicant
Schlaich, Markus P. et al, International Expert Consensus Statement: Percutaneous Transluminal Renal Denervation for the Treatment of Resistant Hypertension, Journal of the American College of Cardiology vol. 62, Issue 22, Dec. 3, 2013, pp. 2031-2045.Applicant
Schlaich, Markus P. et al, Renal Denervation as a Therapeutic Approach for Hypertension Novel Implications for an Old Concept, Hypertension Journal of The American Heart Association, 2009;54:1195-1201.Applicant
Schlaich, Markus P. et al, Renal Sympathetic-Nerve Ablation for Uncontrolled Hypertension, The New England Journal of Medicine, 2009; 361:932-934.Applicant
Schmieder, Roland E. et al, ESH Position Paper: Renal Denervation—An Iterventional Therapy of Resistant Hypertension, Journal of Hypertension, 2012, 30:837-841.Applicant
Schmieder, Roland E. et al, Updated EHS Position Paper on Interventional Therapy of Resistant Hypertension, EuroIntervention 2013; 9:R58-R66.Applicant
Sellers, Alfred M. et al, Adrenalectomy and Sympathectomy for Hypertension Ten Year Survival, Archives of Surgery, vol. 89, Nov. 1964, 880-886.Applicant
Sen, S.K., Some Observations on Decapsulation and Denervation of the Kidney, The British Journal of Urology, vol. 8, Issue 4, Dec. 1936, 319-328.Applicant
Shiraki, Iwao William, Correction of Renal Hypertension by Ligation of Stenotic Segmental Renal Artery, Urology, vol. IX, No. 3, Mar. 1977, 296-298.Applicant
Shonai, Takaharu et al, Renal Artery Aneurysm: Evaluation with Color Doppler Ultrasonography Before and After Percutaneous Transarterial Embolization, J Ultrasound Med 19:277-280, 2000.Applicant
Silver, Donald et al, Renovascular Hypertension From Renal Artery Compression by Congenital Bands, Annals of Surgery, Feb. 1976, 161-166.Applicant
Smith, Gardner W. et al, Surgical Results and the Diagnostic Evaluation of Renovascular Hypertension, Annals of Surgery, May 1968, 669-680.Applicant
Smith, Harold P. et al, Radiofrequency Neurolysis in a Clinical Model Neuropathological Correlation, J Neurosurg 55:246-253, 1981.Applicant
Smithwick, R.H., An Evaluation of the Surgical Treatment of Hypertension, The Bulletin, Nov. 1949; 25(11):698-716.Applicant
Smithwick, Reginald H. et al, Splanchnicectomy for Essential Hypertension, The Journal of the American Medical Association, vol. 152, No. 16, Aug. 1953, 1501-1504.Applicant
Solis-Herruzo, J.A. et al, Effects of Lumbar Sympathetic Block on Kidney Function in Cirrhotic Patients with Hepatorenal Syndrome, Journal of Hepatology, 1987; 5: 167-173.Applicant
Sowers, James R. et al, Diabetes, Hypertension, and Cardiovascular Disease: An Update, Hypertension Journal of The American Heart Association, 2001;37:1053-1059.Applicant
Stanley, James C., Surgical Treatment of Renovascular Hypertension, The American Journal of Surgery, vol. 174, Aug. 1997, 102-110.Applicant
Stella, Andrea et al, Effects of Reversible Renal Denervation on Haemodynamic and Excretory Functions of the Ipsilateral and Contralateral Kidney in the Cat, Journal of Hypertension 1986, 4: 181-188.Applicant
Stuart, Candace, Newest Frontier in Cardiac Care: Kidneys; Cardiovascular Business, Dec. 13, 2012.Applicant
Stuart, Mary, Masterminds of Ardian: An Interview With Inventors Mark Gelfand and Howard Levin, Windhover Information, Start-Up Jan. 1, 2011.Applicant
Sun, Yingxian et al, Risk of Coronary Stenosis with Venous Ablation for Epicardial Accessory Pathways, PACE, Apr. 2001, Part II, vol. 24, 605.Applicant
Swartz, John F. et al, Radiofrequency Endocardial Catheter Ablation of Accessory Atrioventricular Pathway Atrial Insertion Sites, Circulation Journal of The American Heart Association, 1993;87:487-499.Applicant
Teigen, Corey L. et al, Segmental Renal Artery Embolization for Treatment of Pediatric Renovascular Hypertension, Journal of Vascular and Interventional Radiology, 1992; 3:111-117.Applicant
Teixeira, Maria Do Carmo et al,1992; Role of the Peripheral Renin Profile in Predicting Blood Pressure Control After Bilateral Nephrectomy in Renal-Transplanted Patients, Nephrol Dial Transplant (1998) 13: 2092-2097.Applicant
Teo, W S et al, Radiofrequency Catheter Ablation of Accessory Pathways: The Initial Experience in Singapore, Singapore Medical Journal, 1994; vol. 35:36-40.Applicant
Thiebot, J. et al, Bilateral Nephrectomy by Embolization of the Renal Arteries: A Report on Five Cases (author's transl), Sem Hop. Apr. 8-15, 1980;56(13-14):670-5.Applicant
Thomas, George et al, Renal Denervation to Treat Resistant Hypertension: Guarded Optimism, Cleveland Clinic Journal of Medicine, vol. 79, No. 7, Jul. 2012, 501-510.Applicant
Thomas, Natalie A., Secondary Consideration in Nonobviousness Analysis: The Use of Objective Indicia Following KSR V. Teleflex, NYU Law Review, vol. 86, No. 6, Dec. 2011, 2070-2112.Applicant
Ting, Chih-Tai et al, Arterial Hemodynamics in Human Hypertension Effects of Angiotensin Converting Enzyme Inhibition, Hypertension Journal of The American Heart Association, 1993;22:839-846.Applicant
Uchida, Fumiya et al, Effect of Radiofrequency Catheter Ablation on Parasympathetic Denervation: A Comparison of Three Different Ablation Sites, PACE, vol. 21, Nov. 1998, Part II, 2517-2521.Applicant
Valente, John F. et al, Laparoscopic Renal Denervation for Intractable ADPKD-Related Pain, Nephrol Dial Transplant (2001) 16:160.Applicant
Villarreal, Daniel et al, Effects of Renal Denervation on Postprandial Sodium Excretion in Experimental Heart Failure, American Journal of Physiology, May 1994;266(5 Pt 2):R1599-R1604.Applicant
Vonend, Oliver et al, Secondary Rise in Blood Pressure After Renal Denervation, The Lancet, vol. 380, Issue 9843, p. 778, Aug. 25, 2012.Applicant
Vujaskovic, Z. et al, Effects of Intraoperative Hyperthermia on Canine Sciatic Nerve: Histopathologic and Morphometric Studies, Int. J. Hyperthermia, 1994, vol. 10, No. 6, 845-855.Applicant
Webb, R.L. et al, Functional Identification of the Central Projections of Afferent Renal Nerves, Clin. and Exper.—Theory and Practice, Ag(Suppl.I), 47-57 (1987).Applicant
Weinstock, Marta et al, Renal Denervation Prevents Sodium Retention and Hypertension in Salt-Sensitive Rabbits with Genetic Baroreflex Impairment, Clinical Science (1996) 90, 287-293.Applicant
Wilcox, Josiah N., Scientific Basis Behind Renal Denervation for the Control of Hypertension, Medtronic, Inc., Dec. 2012, 38 pages.Applicant
Winternitz, Sherry R. et al, Role of the Renal Sympathetic Nerves in the Development and Maintenance of Hypertension in the Spontaneously Hypertensive Rat, Journal of Clinical Investigation, vol. 66 Nov. 1980, 971-978.Applicant
Wolf-Maier, Katharina et al, Hypertension Treatment and Control in Five European Countries, Canada, and the United States, Hypertension. 2004;43:10-17.Applicant
Wyss, J.M. et al, Sensory Denervation of the Kidney Attenuates Renovascular Hypertension in the Rat, Am J Physiol Heart Circ Physiol 250:H82-H86, 1986.Applicant
Yamada, Yutaka et al, Age-Related Changes in Muscle Sympathetic Nerve Activity in Essential Hypertension, Hypertension Journal of The American Heart Association, 1989;13:870-877.Applicant
Young, Robert R. et al, Reversible Block of Nerve Conduction by Ultrasound Ultrasonic Blocking of Nerve Fibers, Arch Neurol. 1961;4(1):83-89.Applicant

Abstract